Amgen Inc.
LOW PH PHARMACEUTICAL ANTIBODY FORMULATION

Abstract:

The present disclosure describes low pH formulations comprising, e.g., an antigen-binding protein that binds CD3, at least one buffer agent, at least one saccharide and at least one surfactant.